Is surgical smoke a relevant contamination for salvaged autologous blood? A pilot study.

IF 1.8 4区 医学 Q3 HEMATOLOGY
Vox Sanguinis Pub Date : 2025-05-04 DOI:10.1111/vox.70040
Andrea Stadlbauer, Patricia Fiedler, Simon Tuemmler, Michael Gruber, Christof Schmid, Timo F Seyfried
{"title":"Is surgical smoke a relevant contamination for salvaged autologous blood? A pilot study.","authors":"Andrea Stadlbauer, Patricia Fiedler, Simon Tuemmler, Michael Gruber, Christof Schmid, Timo F Seyfried","doi":"10.1111/vox.70040","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Electrocautery-related surgical smoke removed together with the intraoperative blood collection through suction devices might be a potential hazard. The degree of contamination of the autologous blood despite cell recovery and its possible harm to the patient remain subjects of research.</p><p><strong>Materials and methods: </strong>Two types of laboratory experiments and one clinical study were conducted. Initially, toluene was added to banked erythrocytes mixed with fresh frozen plasma. This reconstituted blood was processed using the autotransfusion device XTRA, and the elimination of toluene was calculated via gas chromatography (GC). In a second experiment, slices of pigskin were cut with electrocautery while dropping reconstituted blood onto the cauterization point. The resulting smoke and the blood were sucked into a cell salvage reservoir and washed with the XTRA. Samples from the reservoir and the product were analysed by GC. The average elimination rate was calculated. In a clinical study, blood samples were collected from the reservoir of the cell saver system during cardiac surgery and analysed likewise.</p><p><strong>Results: </strong>The autotransfusion device removed 92% of toluene from the processed blood. Other unidentified contaminants showed an elimination rate above 97.9%.</p><p><strong>Conclusion: </strong>Cell salvage devices significantly reduce the amount of contaminants in wound blood. Nevertheless, despite this highly effective detoxication, the remaining contaminants may still pose a potential risk to the patient.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70040","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Electrocautery-related surgical smoke removed together with the intraoperative blood collection through suction devices might be a potential hazard. The degree of contamination of the autologous blood despite cell recovery and its possible harm to the patient remain subjects of research.

Materials and methods: Two types of laboratory experiments and one clinical study were conducted. Initially, toluene was added to banked erythrocytes mixed with fresh frozen plasma. This reconstituted blood was processed using the autotransfusion device XTRA, and the elimination of toluene was calculated via gas chromatography (GC). In a second experiment, slices of pigskin were cut with electrocautery while dropping reconstituted blood onto the cauterization point. The resulting smoke and the blood were sucked into a cell salvage reservoir and washed with the XTRA. Samples from the reservoir and the product were analysed by GC. The average elimination rate was calculated. In a clinical study, blood samples were collected from the reservoir of the cell saver system during cardiac surgery and analysed likewise.

Results: The autotransfusion device removed 92% of toluene from the processed blood. Other unidentified contaminants showed an elimination rate above 97.9%.

Conclusion: Cell salvage devices significantly reduce the amount of contaminants in wound blood. Nevertheless, despite this highly effective detoxication, the remaining contaminants may still pose a potential risk to the patient.

手术烟雾是否与回收的自体血液有关?一项初步研究。
背景与目的:电灼术相关的手术烟雾清除与术中通过吸引装置采血可能是一种潜在的危害。尽管细胞恢复,自体血液的污染程度及其对患者的可能危害仍是研究的主题。材料与方法:进行两类实验室实验和一项临床研究。最初,将甲苯加入到与新鲜冷冻血浆混合的红细胞中。利用自身输血装置XTRA对重组血液进行处理,并通过气相色谱(GC)计算甲苯的消除量。在第二个实验中,用电切猪皮片,同时在烧灼点上滴入重建血。产生的烟雾和血液被吸进一个细胞回收池,用XTRA清洗。采用气相色谱法对储层样品和产物进行分析。计算平均消去率。在一项临床研究中,在心脏手术期间从细胞保存系统的储存库中收集血液样本并进行同样的分析。结果:自体输血装置去除处理后血液中92%的甲苯。其他未识别污染物的去除率均在97.9%以上。结论:细胞保存装置可显著减少伤口血液中污染物的含量。然而,尽管这种高效的解毒,残留的污染物仍可能对患者构成潜在的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Vox Sanguinis
Vox Sanguinis 医学-血液学
CiteScore
4.40
自引率
11.10%
发文量
156
审稿时长
6-12 weeks
期刊介绍: Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections: 1) Transfusion - Transmitted Disease and its Prevention: Identification and epidemiology of infectious agents transmissible by blood; Bacterial contamination of blood components; Donor recruitment and selection methods; Pathogen inactivation. 2) Blood Component Collection and Production: Blood collection methods and devices (including apheresis); Plasma fractionation techniques and plasma derivatives; Preparation of labile blood components; Inventory management; Hematopoietic progenitor cell collection and storage; Collection and storage of tissues; Quality management and good manufacturing practice; Automation and information technology. 3) Transfusion Medicine and New Therapies: Transfusion thresholds and audits; Haemovigilance; Clinical trials regarding appropriate haemotherapy; Non-infectious adverse affects of transfusion; Therapeutic apheresis; Support of transplant patients; Gene therapy and immunotherapy. 4) Immunohaematology and Immunogenetics: Autoimmunity in haematology; Alloimmunity of blood; Pre-transfusion testing; Immunodiagnostics; Immunobiology; Complement in immunohaematology; Blood typing reagents; Genetic markers of blood cells and serum proteins: polymorphisms and function; Genetic markers and disease; Parentage testing and forensic immunohaematology. 5) Cellular Therapy: Cell-based therapies; Stem cell sources; Stem cell processing and storage; Stem cell products; Stem cell plasticity; Regenerative medicine with cells; Cellular immunotherapy; Molecular therapy; Gene therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信